Kidney function and study drug levels
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study checks how different levels of kidney function affect the levels of a new investigational drug called Ribupatide in the blood. It helps doctors understand how the drug works in people with various kidney conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your body mass index (BMI) must be at least 18.5 at screening.
- If you are a woman, you must not be pregnant, planning to become pregnant, or breastfeeding during the study and for 35 days after the drug dose.
- You must have suitable veins for blood draws.
- You must not have significant heart, lung, liver, kidney, blood, stomach, hormone, immune, skin, psychiatric, or brain disease in the past 3 months.
- You must not have had certain weight-loss or diabetes drugs (like semaglutide, tirzepatide, or similar) within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how the allergy medicine rupatadine moves through the body and how safe it is for people with different levels of kidney function, compared to people with healthy kidneys.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study looks at how a new injection (HDM1005) is processed by the body in people with different levels of kidney function, including healthy volunteers. It aims to help understand dosing for people with kidney issues.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This study tests a GLP-1 receptor agonist (a type of medicine that helps with weight and metabolism) in people with polycystic kidney disease who are overweight. It aims to see if this drug can help slow kidney disease progression.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.